News

  • Letter to HHS on ICD-10 Implementation

    March 28, 2012
    March 28, 2012 The Honorable Kathleen Sebelius Secretary Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, DC 20201 Re: ICD-10-CM Implementation Dear Secretary Sebelius, I am writing to you on behalf of the American Clinical Laboratory Association (ACLA) to urge the Department of Health and Human Services (HHS) to adopt several important recommendations as theContinue Reading »...
  • Letter to Reps Kind and Price Regarding Health Information Technology Reform Act

    March 14, 2012
      March 14, 2012 The Honorable Ron Kind 1406 Longworth House Office Building Washington, DC 20515 The Honorable Tom Price 403 Cannon House Office Building Washington, DC 20515 Dear Congressmen Kind and Price: On behalf of the American Clinical Laboratory Association (ACLA), I am writing in support of the Health Information Technology Reform Act, HR 4066, which seeks to exclude pathologists from incentive paymentsContinue Reading »...
  • Letter to Speaker Boehner and Majority Leader Reid Regarding Medicare Clinical Laboratory Fee Schedule

    March 06, 2012
      March 6, 2012 The Honorable John A. Boehner Speaker U.S. House of Representatives H-232, The Capitol Washington, DC 20515 The Honorable Harry Reid Majority Leader U.S. Senate S-221, The Capitol Washington, DC 20510 Dear Speaker Boehner and Leader Reid: I am writing you today on behalf of the American Clinical Laboratory Association (ACLA), which represents the leading national, regional, esoteric, and pathology clinicalContinue Reading »...
  • Big Cuts in Reimbursement for Medicare Lab Tests will Hurt Patients, says ACLA

    March 06, 2012
      Cumulative cuts from recently enacted legislation total 23% over next 10 years Washington, DC — Recently enacted budget cuts that would slash Medicare reimbursement for clinical laboratory tests by 23% over the next 10 years threaten the ability of clinical labs to serve Medicare patients, according to a letter that the American Clinical Laboratory Association sent today to House Speaker John Boehner andContinue Reading »...
  • Comments Regarding Sunshine Rule

    February 17, 2012
      February 17, 2012 Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS—5060—-P Mail Stop C4—26—05 7500 Security Boulevard Baltimore, MD 21244-1850 RE: CMS-5060-P Transparency Reports and Reporting of Physician Ownership or Investment Interests Dear Acting Administrator Tavenner: The American Clinical Laboratory Association (ACLA) appreciates the opportunity to provide comments to the Centers for Medicare & Medicaid Services (CMS)Continue Reading »...
  • Comments on Coverage with Evidence Development

    January 18, 2012
      January 18, 2012 Louis Jacques, MD Director, Coverage and Analysis Group Office of Clinical Standards Quality Centers for Medicare and Medicaid Services 7500 Security Blvd Baltimore, Maryland 21244 RE: Coverage with Evidence Development (CED) Public Comment & Solicitation Dear Dr. Jacques, The American Clinical Laboratory Association (“ACLA”) is pleased to have this opportunity to submit comments to the Centers for Medicare and MedicaidContinue Reading »...
  • Comments on J11 Draft LCD for Molecular Diagnostic Tests

    January 16, 2012
      January 16, 2012 Dr. Elaine Jeter Medical Director Palmetto GBA (J11 MAC) P.O. Box 100190 Columbia, South Carolina 29202 RE: Palmetto GBA Draft Local Coverage Determination (LCD) for Molecular Diagnostic Tests (MDT) (DL 32394) Dear Dr. Jeter: The American Clinical Laboratory Association (“ACLA”) hereby submits comments on Palmetto GBA’s (“Palmetto’s”) Draft Local Coverage Determination (“LCD”) for Molecular Diagnostic Tests.1 ACLA is an associationContinue Reading »...
  • Lab Tests Critical to Detecting 79 Million Americans on Brink of Developing Diabetes

    January 10, 2012
    Washington DC — Laboratory tests are a critical component in helping the US confront the diabetes epidemic that is projected to cost $514 billion by 2025 – an increase of more than 100 percent and comparable to the total budget of today’s Medicare program. Results for Life, an educational campaign focused on the value of laboratory medicine, applauds an article in the January issueContinue Reading »...
  • Letter to CMS Regarding Saturation Biopsy

    December 10, 2011
        December 10, 2011   Mr. Marc Hartstein, Acting Director Hospital and Ambulatory Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244   Dear Mr. Hartstein:   On behalf of the American Clinical Laboratory Association (“ACLA”), I am writing to express our concerns about CMS’s recent actions with respect to HCPCS code G0416, which isContinue Reading »...
  • Letter to Chairman Baucus and Ranking Member Hatch Regarding TC “Grandfather” Provision

    December 07, 2011
        December 7, 2011   The Honorable Max Baucus Chairman Senate Finance Committee Washington, DC 20510   The Honorable Orrin Hatch Ranking Member Senate Finance Committee Washington, DC 20510   Dear Chairman Baucus and Ranking Member Hatch:   The undersigned organizations, representing laboratories, hospitals, laboratory professionals, physicians, and the patients we serve, urge you to extend an expiring provision that would ensure hospitalsContinue Reading »...